TMS therapy for Deerfield Beach — FDA-cleared TRD care, 22 minutes from home.

RECO Health operates its TMS suite at the Delray Beach campus, 22 minutes north of Deerfield Beach along I-95 or A1A. In-house psychiatry handles prior authorization, motor threshold mapping, and the daily 10 Hz rTMS course at 120% MT — with iTBS available where the insurance plan reimburses it. Clients from The Cove, Pioneer Park, and Hillsboro Beach typically maintain their existing outpatient therapist and employment schedule throughout the six-week acute phase and three-week taper.

Deerfield Beach sits 13 miles south of RECO Health’s Delray Beach campus — a 22-minute run up A1A or I-95 that most clients drive themselves to each session. For residents of The Cove, Pioneer Park, Hillsboro Beach, Cresthaven, and the Goldcoast Centre corridor, that drive puts a full FDA-cleared TMS course within reach without dislocating work, family, or established outpatient care.

Who is a candidate for rTMS

Repetitive Transcranial Magnetic Stimulation is FDA-cleared for major depressive disorder that has not responded to standard pharmacotherapy. The insurance-covered indication requires documented failure of at least two adequate antidepressant trials — adequate meaning target dose, minimum six-week duration, and confirmed adherence. Common entries on the failed-trial list include sertraline, escitalopram, venlafaxine, bupropion, and duloxetine at therapeutic doses; augmentation trials with aripiprazole, quetiapine, or lithium also count toward the two-trial threshold.

Clinical candidacy extends beyond the pharmacology history. RECO Health’s psychiatry team screens for absolute and relative contraindications: implanted metallic devices near the head (cochlear implants, aneurysm clips, deep brain stimulators), prior seizure history, active substance use that would confound response, and unstable bipolar disorder. Baseline PHQ-9 and GAD-7 scores are documented at intake, and comorbid conditions — OCD scored by YBOCS, adult ADHD by ASRS — are noted for treatment planning. On the Deep TMS platform, an OCD indication is separately available for clients who meet YBOCS severity criteria.

Prior authorization is handled in-house. The intake coordinator assembles the medication trial documentation, the psychiatrist writes the clinical justification, and most commercial carriers issue a decision within five to ten business days.

The 36-session protocol and what it looks like

Session one is not a treatment session — it is motor threshold mapping. The clinician positions the figure-8 coil over the motor cortex and delivers single pulses at incremental intensities until the minimum output that reliably produces a contralateral thumb twitch is identified. Treatment intensity is then set at 120% of that motor threshold. The coil is repositioned five to six centimeters anterior along the Beam F3 landmark to sit over the left dorsolateral prefrontal cortex — the target for depression.

Sessions two through thirty run daily Monday through Friday for six weeks. The standard NeuroStar protocol delivers 3000 pulses at 10 Hz — four seconds on, twenty-six seconds off — across roughly 37 minutes in the chair. Clients sit reclined and awake, can talk or read, and return directly to work or school afterward. Scalp discomfort at the stimulation site is the most common adverse effect and generally resolves within the first week. The seizure risk on standard rTMS protocols is under one in thirty thousand sessions.

The final six sessions are the taper: three per week, then two, then one. The taper is not padding — it consolidates response and reduces early relapse rates in the published literature. Missed sessions during the acute phase are made up wherever possible to preserve daily continuity.

Response, remission, and the second-course question

Published response rates for rTMS in treatment-resistant depression run 40 to 60 percent, with remission rates of 25 to 40 percent, depending on the protocol and the definition applied. Response is defined as a 50 percent reduction in PHQ-9 or Montgomery-Asberg score; remission as scores in the non-depressed range. Response typically emerges between sessions 15 and 25, with continued gains through the taper.

Clients who show no measurable movement by session 20 to 25 trigger a case review. Sometimes the coil position warrants re-verification against the Beam F3 landmark. Sometimes a protocol switch to intermittent theta burst is indicated. Sometimes the more accurate answer is that the case belongs on the ketamine or esketamine pathway rather than TMS — the RECO psychiatry team runs both and makes that recommendation without loyalty to the modality already started.

Responders who later relapse — most commonly at the six to twelve month mark — are candidates for a second full course. Insurance carriers generally cover a second course when the first produced documented response and remission followed by recurrence. Maintenance TMS at a weekly or biweekly cadence is offered off-label for a subset of clients whose relapse pattern predicts benefit.

iTBS and the shorter-session option

Intermittent Theta Burst Stimulation is an FDA-cleared alternative rTMS protocol. iTBS delivers 600 pulses in a three-minute session using triplet bursts at 50 Hz repeated at 5 Hz. The THREE-D trial demonstrated non-inferiority to standard 10 Hz rTMS across response and remission endpoints in treatment-resistant depression. For a Deerfield Beach client whose workday cannot accommodate a 40-minute treatment window plus travel, iTBS makes daily treatment logistically feasible without compromising the evidence base.

Coverage varies. Most commercial carriers reimburse iTBS at parity with 10 Hz rTMS, but not all — Florida Blue, Aetna, Cigna, UnitedHealthcare, and Humana each maintain distinct policies that shift year over year. Coverage is confirmed in writing before enrollment; where iTBS is not covered, standard 10 Hz rTMS remains the default protocol.

What to expect on your first visit

The first visit is a psychiatric evaluation, not a stimulation session. The psychiatrist reviews the depression history, prior medication trials with doses and durations, current medications, medical history relevant to seizure risk and metallic implants, substance use history, and family psychiatric history. PHQ-9, GAD-7, and — where relevant — YBOCS and ASRS are administered. The evaluation runs 60 to 90 minutes.

Motor threshold mapping is scheduled separately, usually within a week of prior authorization approval. Treatment begins the same day as mapping or the following business day. Clients are asked to eat normally beforehand, take routine medications as prescribed, avoid initiating new stimulants without prior discussion, and bring a photo ID and insurance card to the first two visits.

Concurrent care continues. RECO’s TMS clients frequently remain on their pre-treatment antidepressant, engage in weekly individual therapy — CBT, ACT, or behavioral activation are the common frames — and, where indicated, participate in DBT skills training or motivational interviewing for co-occurring substance use. TMS is not delivered in isolation.

Insurance and admissions from Deerfield Beach

RECO Health is in-network with Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS plans. TMS benefits are verified against the specific plan before the first appointment; the two-antidepressant-trial requirement is universal, but session limits, iTBS parity, and second-course rules vary carrier to carrier. Out-of-pocket exposure — deductible, coinsurance, and per-session copay — is quantified in writing before the client commits to the six-week course.

The 22-minute drive is short enough that most Deerfield Beach clients keep their existing outpatient therapist, primary care physician, and employment schedule intact. The intake team coordinates release of information with outside providers so that daily TMS therapy notes, PHQ-9 trajectories, motor threshold values, and any medication adjustments flow back to the client’s home team throughout the acute and taper phases.

Serving residents of: The Cove, Pioneer Park, Hillsboro Beach, Cresthaven, Goldcoast Centre.